Investigation of the customer's issue included a review of the complaint text, complaint activity, trending reports, labeling and device history records.Additionally, in-house retained kit testing of the complaint lot was performed.Return testing was not completed as returns were not available.Review of the trending reports for the architect insulin assay did not identify any trends.Device history record review for the complaint lot did not identify any potential non-conformances, deviations or non-conformances.Labeling was reviewed and sufficiently addresses the complaint issue.Accuracy testing was performed to evaluate the performance of reagent lot 29821lp68.An internal insulin panel was tested with retained kits of the complaint lot.Acceptance criteria was met indicating the product performance is acceptable.Based on this investigation, no systemic issue or deficiency of the architect insulin assay was identified.H4 device mfg date was changed from 4/7/2021 to 4/27/2021.The incorrect date was entered in error.
|